3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Multiple Myeloma
14
Lymphoma, Non-Hodgkin
12
Leukemia, Myeloid, Acute
12
Leukemia
5
Hodgkin Disease
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Chemotherapy-induced Neutropenia
3
Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Plasmacytoma
2
Paraproteinemias
2
Neutropenia
2
Neoplasm Metastasis
2
Leukemia, Plasma Cell
2
Chemotherapy Induced Neutropenia
2
Carcinoma, Non-Small-Cell Lung
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
pegylated granulocyte colony-stimulating factor, human
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Chemotherapy Induced Neutropenia
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT01674855
2014-10-01
PEG-G-CSF
Dong-A ST Co., Ltd.
Phase 3
Completed
74 enrolled
NCT01923545
2014-10-01
PEG-G-CSF
Dong-A ST Co., Ltd.
Phase 2
Completed
61 enrolled